Arab Finance: El Nile Company for Pharmaceuticals and Chemical Industries (Nile Pharma) (NIPH) reported a 39.19% year-on-year (YoY) increase in net profits for fiscal year (FY) 2022/2023, according to the financial income statement filed to the Egyptian Exchange (EGX) on August 15th.

Net profits amounted to EGP 118.965 million in FY 2022/2023, compared to EGP 89.672 million in the FY before.

Operating revenues climbed 15.5% YoY to EGP 1.012 billion in the FY ended June 30th, 2023, compared to EGP 876.780 million in FY 2021/2022.

Nile Pharma manufactures and markets pharmaceuticals, various types of medical materials, chemical products, and cosmetics, as well as surgical threads and medical solutions.

Gadwa’s consolidated profits fall 46.6% YoY in 9 months Updated 11/27/2025 10:24:00 AM

Pioneers properties' consolidated profits drop 76.9% YoY in 9 months Updated 11/27/2025 9:26:00 AM

Panda turns to losses in 9 months Updated 11/23/2025 9:42:00 AM

EFG Holding’s consolidated profits drop 13.44% YoY in 9 months Updated 11/19/2025 1:29:00 PM

Contact Financial's total operating income up 17% YoY in 9 months Updated 11/18/2025 10:17:00 AM